CV9104 (Prostate Carcinoma Vaccine) — Pipeline & Regulatory Status

Program Status: Inactive / Discontinued

Reason: Registry status: TERMINATED

Stage at discontinuation: phase_2

Development Phase Discontinued / Inactive Primary Status

Platform Technology Biological (unspecified platform) Biologic Architecture

Target Indication Prostate Carcinoma Pathogen / Antigen

Last Verified 2026-07-10 Tier 1 Multi-Source Checked

Multi-Jurisdiction Regulatory Status

Official licensing, rolling submissions, or authorization status tracked across major health authorities.

Regulatory Authority	Status & Details
US FDA	Not Filed / Pre-submission
EMA (Europe)	Not Filed / Pre-submission
Health Canada	Not Filed / Pre-submission
TGA (Australia)	Not Filed / Pre-submission

Scientific Profile & Documentation

Platform Architecture: Biological (unspecified platform)
Lead Developer: CureVac
Next Expected Milestone: Primary completion (most advanced trial): 2016-04 (registry estimate)
Analyst & Development Notes: Auto-grouped from 2 ClinicalTrials.gov record(s) sharing intervention/sponsor. Phases and timelines are registry fields and may lag company disclosures.
Primary Source Documentation: ClinicalTrials.gov NCT02140138 →
Additional Sources & Literature: NCT01817738 on ClinicalTrials.gov (2026-07-10)

Registered Clinical Trials & Studies

Direct registry links to active, completed, or pivotal registration studies across phases.

NCT02140138 Discontinued / Inactive

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Can

Status: Active / Ongoing • Expected Readout: 2016-04

NCT01817738 Discontinued / Inactive

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

Status: Active / Ongoing • Expected Readout: 2016-08

Milestone Overview

Stage Verification

Discontinued / Inactive confirmed as of 2026-07-10.
Target Milestone

Primary completion (most advanced trial): 2016-04 (registry estimate)

Vaccine Data Navigator Candidate Profile Registry:

This candidate profile is indexed across all clinical development levels (Preclinical through Phase 1–3, Regulatory Filing, and Licensure) from primary registry databases (ClinicalTrials.gov, WHO ICTRP, FDA CBER, EMA, Health Canada, TGA Australia). Data are updated continuously to track global biologic and vaccine pipelines.